Skip to content

Phathom Pharmaceuticals, Inc. PHAT Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

Opko Health logo
Opko HealthOPK
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
AMP
Amphastar PharmaceuticalsAMPH
Theravance Biopharma logo
Theravance BiopharmaTBPH
Precigen logo
PrecigenPGEN
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO

Other financials

Income statement

See full
Revenue$58.3M+104%
Gross profit$46.3M+86.8%
Operating income-$15.5M+80.4%
Net income-$30.4M+67.8%
EPS (diluted)-$0.37+71.8%

Balance sheet

See full
Cash & equivalents$180.9M-14.8%
Total debt$166.3M-18.3%
Total equity-$337.0M+0.4%
Total assets$305.1M+3.7%

Cash flow

See full
Operating cash flow-$15.6M+81.6%
CapEx$61.0K+239%
Free cash flow-$15.7M+81.5%

Valuation

See full
Market cap$824.68M+13.4%
Enterprise value$810.08M+12.7%
P/S-4.9×

Profitability

See full
Gross margin84.9%-1.3pp
Operating margin-47.1%-21.9pp
Net margin-76.8%-34.5pp
FCF margin-47.7%-22.1pp

Returns & leverage

See full
Return on equity-147.9%
Debt / equity5.6×
Current ratio2.2×-1.4×

Where this comes from

Reported directly by Phathom Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Phathom Pharmaceuticals, Inc.'s software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Phathom Pharmaceuticals, Inc.'s software and technology licenses, net?
Phathom Pharmaceuticals, Inc. (PHAT) reported software and technology licenses, net of $3.09M in Q1 2026.
How has Phathom Pharmaceuticals, Inc.'s software and technology licenses, net changed year-over-year?
Phathom Pharmaceuticals, Inc.'s software and technology licenses, net increased by 82.4% year-over-year, from $1.69M to $3.09M.
What is the long-term trend for Phathom Pharmaceuticals, Inc.'s software and technology licenses, net?
Over 5 years (2020 to 2025), Phathom Pharmaceuticals, Inc.'s software and technology licenses, net has grown at a 50.0% compound annual growth rate (CAGR), from $384K to $2.92M.